Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Innovent's NDA Filing for Humira Biosimilar Accepted in China
Generon to Start China Phase I Trial of IO Drug in B Cell Malignancies
Innovent Starts Phase III Trial of PD-1 Candidate in Lung Cancer Patients
I-Mab Approved to Start China Trials of Interleukin-7 Immunotherapy
Bio-Thera Starts China Phase III Trial of HER2 Conjugate Drug
Upcoming event
ChinaBio Partnering Forum 2019
Shanghai , China
May 8-9, 2019
 
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

ChinaBio® Events